Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cyclosporine A for the Treatment of Dry Eye
NCT04714099Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Jan 2015
- Primary completion
- Dec 2015
01
Overview
Phase 3, randomised, double-blind trial of CyclAGel in dry eye disease (DED) (2 arms), sponsored by Alexandria University. Primary endpoint: Tear Break up Time at 3 months. Started Jan 2015; status: completed.
02
Drugs
CyclAGel
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04714099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714099.